Keywords: regeneron, enters, phase, ii, study, pharmaceuticals, begun

REGENERON ENTERS PHASE II STUDY

Article | 25 January 1993

Print This

Regeneron Pharmaceuticals has begun a Phase II study in the USA of its recombinant human ciliary neutrophic factor for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in